Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (181-190 of 387) with videos related to

Pageof 39
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 28, 2021
Scan-rescan measurement repeatability of <sup>18</sup>F-FDG PET/MR imaging of vascular inflammationPhilip M Robson, Audrey Kaufman, Alison Pruzan, et al.
Journal of the American Academy of Dermatology|October 26, 2017
The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumabAmy S Paller, Tali Czarnowicki, Yael Renert-Yuval, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 4, 2026
Epidemiology of Adult Atopic Dermatitis in High-Burden Skin Areas: Results From a Cross-Sectional Patient SurveyAmalie Thorsti Møller Rønnstad, Mia-Louise Nielsen, Anne-Sofie Halling, et al.
Journal of the American Academy of Dermatology|May 8, 2020
Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulationJacob W Glickman, Celina Dubin, Yael Renert-Yuval, et al.
Dermatology and Therapy|May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records DatasetLawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.
American Journal of Clinical Dermatology|January 27, 2026
Long-Term Real-World Evaluation of Abrocitinib in Moderate-to-Severe Atopic Dermatitis Across a Diverse Patient Population in a Multi-site Hospital SystemMegan Lau, Joseph Largen, Jasmine Levine, et al.
Journal of the American Academy of Dermatology|April 13, 2023
Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skinMadeline Kim, Ester Del Duca, Julia Cheng, et al.
The Journal of Allergy and Clinical Immunology|June 28, 2011
Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsetsHideki Fujita, Avner Shemer, Mayte Suárez-Fariñas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasisEmma Guttman-Yassky, Michelle A Lowes, Judilyn Fuentes-Duculan, et al.
Journal of Drugs in Dermatology : JDD|February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in PracticeMark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
Pageof 39

Showing results (181-190 of 387) with videos related to

Sort By:
Pageof 39
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 28, 2021
Scan-rescan measurement repeatability of <sup>18</sup>F-FDG PET/MR imaging of vascular inflammationPhilip M Robson, Audrey Kaufman, Alison Pruzan, et al.
Journal of the American Academy of Dermatology|October 26, 2017
The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumabAmy S Paller, Tali Czarnowicki, Yael Renert-Yuval, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 4, 2026
Epidemiology of Adult Atopic Dermatitis in High-Burden Skin Areas: Results From a Cross-Sectional Patient SurveyAmalie Thorsti Møller Rønnstad, Mia-Louise Nielsen, Anne-Sofie Halling, et al.
Journal of the American Academy of Dermatology|May 8, 2020
Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulationJacob W Glickman, Celina Dubin, Yael Renert-Yuval, et al.
Dermatology and Therapy|May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records DatasetLawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.
American Journal of Clinical Dermatology|January 27, 2026
Long-Term Real-World Evaluation of Abrocitinib in Moderate-to-Severe Atopic Dermatitis Across a Diverse Patient Population in a Multi-site Hospital SystemMegan Lau, Joseph Largen, Jasmine Levine, et al.
Journal of the American Academy of Dermatology|April 13, 2023
Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skinMadeline Kim, Ester Del Duca, Julia Cheng, et al.
The Journal of Allergy and Clinical Immunology|June 28, 2011
Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsetsHideki Fujita, Avner Shemer, Mayte Suárez-Fariñas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasisEmma Guttman-Yassky, Michelle A Lowes, Judilyn Fuentes-Duculan, et al.
Journal of Drugs in Dermatology : JDD|February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in PracticeMark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
Pageof 39